Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2681-2690 Newer>

Pharmaceutical Executive February 1, 2006 Jere Doyle	Alternative Media: How to Capture Your Target Consumers' Profile Data Online To better target and keep track of consumers, some pharmaceutical companies have developed online customer-acquisition programs, a marketing approach that identifies consumers who are interested in learning about drug treatments for their specific ailments.
Pharmaceutical Executive February 1, 2006 Bryan Luce	Back Page: Taking Hold of the Wheel Healthcare decision makers do not consistently consider drugs' value. FDA needs to be pressured to change its stance on communicating economic evidence.
Pharmaceutical Executive February 1, 2006 Jill Wechsler	Washington Report: Cross-Agency Collaboration for Part D Medicare Part D gives CMS more clout over coverage, pricing, and even drug development.
Pharmaceutical Executive February 1, 2006 Patrick Clinton	From the Editor: Terrorism: The Cliff Notes A summary of the plot summary of The Karasik Conspiracy.
Pharmaceutical Executive February 1, 2006 Porth & Sillup	Annual Press Audit: Front Page Pharma Newspapers in a study pool published more than twice as many front-page and editorial-page stories on the pharmaceutical industry than they did last year.
Pharmaceutical Executive February 1, 2006 Sarah Houlton	Global Report: Moving Towards Generic Biologics The European Medicines Agency hopes to complete its guidelines for the approval of biosimilar drugs early this year, paving the way for the approval of biogenerics - and a potential goldmine for the generics companies.
Pharmaceutical Executive February 1, 2006 Alana Klein	Thought Leader: Q&A with Ed Broughton Eisai executive Ed Broughton discusses new business opportunities, and what types of partnerships are up next for the growing pharmaceutical company.
Pharmaceutical Executive February 1, 2006 Peter Pitts	Opinion: The Media Attacks Ghostwritten Articles Is it right and appropriate for pharmaceutical companies to be involved in the drafting of medical journal articles that are based on their own studies of their own products.
Pharmaceutical Executive February 1, 2006 Ron Feemster	Gene Logic: Rescue Squad One or two late-stage clinical failures can land promising drug candidates on the shelf. Forever? Maybe not. Gene Logic tests Big Pharma's dead drugs for hundreds of different targets.
Managed Care January 2006	Is Managed Consumerism the 'Third Way'? The health care economist says that consumers ought to share in the savings from making the right choices. Insurers, providers, and hospitals should make sure that options exist.
<Older 2681-2690 Newer> Return to current articles.